HIGHLIGHTS
- who: (revision and colleagues from the Gadjah Mada, Yogyakarta, Indonesia University Magdeburg, Magdeburg, Germany have published the paper: p53 Mutation as Plausible Predictor for Endocrine Resistance Therapy in Luminal Breast Cancer [version 2; peer, in the Journal: (JOURNAL)
- what: The aim of this review is to explore the knowledge of p53 role in Estrogen Receptor and Progesterone Receptor molecular actions thus aggravating the Endocrine Therapy resistance in Luminal Breast Cancer from which the authors could define possibilities and limitations to utilize p53 as the predictive biomarker of endocrine therapy resistance in Luminal Breast Cancer.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.